Page last updated: 2024-09-04

levofloxacin and citric acid, anhydrous

levofloxacin has been researched along with citric acid, anhydrous in 2 studies

Compound Research Comparison

Studies
(levofloxacin)
Trials
(levofloxacin)
Recent Studies (post-2010)
(levofloxacin)
Studies
(citric acid, anhydrous)
Trials
(citric acid, anhydrous)
Recent Studies (post-2010) (citric acid, anhydrous)
4,3465812,20911,8947834,366

Protein Interaction Comparison

ProteinTaxonomylevofloxacin (IC50)citric acid, anhydrous (IC50)
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
Chain A, Proto-oncogene Tyrosine-protein Kinase SrcHomo sapiens (human)40000
perilipin-5Homo sapiens (human)4.5885
perilipin-1Homo sapiens (human)3.708
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform aHomo sapiens (human)4.5885

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Laksana, AN; Nugrahani, I; Oyama, H; Uekusa, H1

Other Studies

2 other study(ies) available for levofloxacin and citric acid, anhydrous

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
New Organic Salt from Levofloxacin-Citric Acid: What Is the Impact on the Stability and Antibiotic Potency?
    Molecules (Basel, Switzerland), 2022, Mar-27, Volume: 27, Issue:7

    Topics: Anti-Bacterial Agents; Antioxidants; Citric Acid; Levofloxacin; Spectroscopy, Fourier Transform Infrared

2022